AXL inhibition prevents RPA2/CHK1-mediated homologous recombination to increase PARP inhibitor sensitivity in hepatocellular carcinoma

AXL抑制可阻止RPA2/CHK1介导的同源重组，从而提高肝细胞癌对PARP抑制剂的敏感性。